The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Agenus; OncXerna Therapeutics; Treos Bio; Verastem
Stock and Other Ownership Interests - Agenus; OncXerna Therapeutics; Treos Bio; Verastem
Consulting or Advisory Role - C4 Therapeutics

A phase I dose-escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma: Interim update.
 
Chao Yin
No Relationships to Disclose
 
John Marshall
Employment - Caris Life Sciences; Indivumed
Leadership - 2curex
Honoraria - Bayer/Onyx; Caris Life Sciences; Daiichi Sankyo/Lilly; Merck; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Bayer/Onyx; Merck; Taiho Pharmaceutical
 
Laura Macke
No Relationships to Disclose
 
Kerrie Bouker
No Relationships to Disclose
 
Aiwu Ruth He
Consulting or Advisory Role - Eisai; Genentech/Roche; Merck
Speakers' Bureau - bms; Eisai; Exelixis
Research Funding - Genentech; Merck
 
Benjamin Adam Weinberg
Employment - Apple (I)
Stock and Other Ownership Interests - Apple (I)
Honoraria - Rafael Pharmaceuticals
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Bayer; HalioDx
Speakers' Bureau - AstraZeneca; Bayer; Diiachi Sankyo; HalioDx; Lilly; Sirtex Medical; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Ipsen (Inst); Isofol Medical (Inst); Novartis (Inst)
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Boehringer Ingelheim; Caris Life Sciences
 
Louis M. Weiner
No Relationships to Disclose
 
Hongkun Wang
No Relationships to Disclose
 
Nabeel Badri
No Relationships to Disclose
 
Nigel Biswas-Baldwin
No Relationships to Disclose
 
Frank Hoke
No Relationships to Disclose
 
Hagop Youssoufian
No Relationships to Disclose
 
Iman El-Hariry
Employment - ERYTECH Pharma
Leadership - ERYTECH Pharma
Stock and Other Ownership Interests - ERYTECH Pharma
Travel, Accommodations, Expenses - ERYTECH Pharma
 
Marcus Smith Noel
Consulting or Advisory Role - Celgene; Ipsen; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Daiichi Sankyo/Astra Zeneca; Taiho Pharmaceutical